Humalog or Humulin for Intensive Insulin Therapy in Intensive Care Unit
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
Insulin preparation -random assignment to regular insulin lin or lispro insulin as first
treatment- was administered at constant infusion rate (0.04 units/Kg/h) in patients
presenting blood glucose concentration ≥180 mg/dl and was discontinued when blood glucose
concentration ≤140 mg/dl (therapeutic blood glucose concentration drop). Further reduction in
blood glucose concentration after discontinuation of insulin infusion was recorded
(post-infusional blood glucose concentration drop). During the study period blood glucose
concentration, in whole blood, was measured every 30 minutes. At least 6 hours interval was
allowed between the 2 treatments.